Puma Biotechnology (PBYI) News Today → The Overlooked Retirement Asset You Probably Don’t Own (From Crypto 101 Media) (Ad) Free PBYI Stock Alerts $4.10 -0.32 (-7.25%) (As of 05/17/2024 ET) Add Compare Share Share HeadlinesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 11, 2024 | americanbankingnews.comPuma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above 200 Day Moving Average of $4.74May 11, 2024 | americanbankingnews.comPuma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.com to "Hold"May 5, 2024 | finance.yahoo.comAnalysts Have Lowered Expectations For Puma Biotechnology, Inc. (NASDAQ:PBYI) After Its Latest ResultsMay 4, 2024 | finance.yahoo.comPuma Biotechnology First Quarter 2024 Earnings: EPS Beats Expectations, Revenues LagMay 3, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Rating Increased to Buy at StockNews.comStockNews.com upgraded shares of Puma Biotechnology from a "hold" rating to a "buy" rating in a report on Friday.May 3, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Stock Rating Reaffirmed by HC WainwrightHC Wainwright reissued a "buy" rating and issued a $7.00 target price on shares of Puma Biotechnology in a report on Friday.May 3, 2024 | markets.businessinsider.comBuy Rating Affirmed for Puma Biotechnology Amid Strong Q1 Performance and Promising OutlookMay 3, 2024 | finance.yahoo.comPuma Biotechnology, Inc. (NASDAQ:PBYI) Q1 2024 Earnings Call TranscriptMay 3, 2024 | finance.yahoo.comPuma Biotechnology Inc (PBYI) Q1 2024 Earnings Call Transcript Highlights: A Detailed Review of ...May 2, 2024 | investorplace.comPBYI Stock Earnings: Puma Biotechnology Beats EPS, Beats Revenue for Q1 2024May 2, 2024 | msn.comPuma Biotechnology Non-GAAP EPS of -$0.05 beats by $0.10, revenue of $43.8M misses by $5.25MMay 2, 2024 | businesswire.comPuma Biotechnology Reports First Quarter Financial ResultsMay 1, 2024 | msn.comPuma Biotechnology Q1 2024 Earnings PreviewMay 1, 2024 | markets.businessinsider.comPuma Biotechnology is about to announce its earnings — here's what Wall Street expectsApril 29, 2024 | finance.yahoo.comIs Puma Biotechnology, Inc. (NASDAQ:PBYI) A High Quality Stock To Own?April 24, 2024 | nasdaq.comPBYI Crosses Above Average Analyst TargetApril 19, 2024 | investorplace.com7 Stocks Under $15 Predicted to Boom in the Next 2 YearsApril 18, 2024 | businesswire.comPuma Biotechnology to Host Conference Call to Discuss First Quarter 2024 Financial ResultsApril 10, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Downgraded by StockNews.comStockNews.com lowered Puma Biotechnology from a "buy" rating to a "hold" rating in a report on Wednesday.April 8, 2024 | finance.yahoo.comPuma Biotechnology (NASDAQ:PBYI) shareholders have earned a 93% return over the last yearApril 5, 2024 | marketbeat.comEquities Analysts Issue Forecasts for Puma Biotechnology, Inc.'s FY2025 Earnings (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Equities researchers at Zacks Research cut their FY2025 earnings estimates for Puma Biotechnology in a research note issued to investors on Wednesday, April 3rd. Zacks Research analyst K. Shah now expects that the biopharmaceutical company wiApril 3, 2024 | businesswire.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)March 22, 2024 | finance.yahoo.comDo Puma Biotechnology's (NASDAQ:PBYI) Earnings Warrant Your Attention?March 22, 2024 | marketbeat.comQ1 2024 EPS Estimates for Puma Biotechnology, Inc. Decreased by Zacks Research (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Analysts at Zacks Research decreased their Q1 2024 EPS estimates for shares of Puma Biotechnology in a research note issued to investors on Tuesday, March 19th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical companyMarch 21, 2024 | marketbeat.comPuma Biotechnology, Inc. to Post FY2026 Earnings of $0.56 Per Share, Zacks Research Forecasts (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Analysts at Zacks Research issued their FY2026 earnings estimates for shares of Puma Biotechnology in a note issued to investors on Tuesday, March 19th. Zacks Research analyst K. Shah forecasts that the biopharmaceutical company will post earMarch 21, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Share Price Crosses Above Two Hundred Day Moving Average of $4.13Puma Biotechnology (NASDAQ:PBYI) Stock Price Crosses Above Two Hundred Day Moving Average of $4.13March 20, 2024 | markets.businessinsider.comPuma Biotechnology: FDA Allows To Proceed With Clinical Development Of AlisertibMarch 20, 2024 | finance.yahoo.comPuma Biotechnology Announces FDA Allowance to Proceed Under IND for Alisertib in HER2-Negative, Hormone Receptor-Positive Metastatic Breast CancerMarch 2, 2024 | markets.businessinsider.comBuy Rating on Puma Biotechnology Amid Financial Challenges and Drug Advancement ProspectsMarch 2, 2024 | finance.yahoo.comPuma Biotechnology, Inc. (NASDAQ:PBYI) Shares Could Be 47% Below Their Intrinsic Value EstimateMarch 2, 2024 | seekingalpha.comPuma Biotechnology, Inc. (PBYI) Q4 2023 Earnings Call TranscriptMarch 1, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) PT Lowered to $7.00 at HC WainwrightHC Wainwright dropped their price objective on Puma Biotechnology from $8.00 to $7.00 and set a "buy" rating on the stock in a research report on Friday.February 29, 2024 | businesswire.comPuma Biotechnology Reports Fourth Quarter and Full Year 2023 Financial ResultsFebruary 27, 2024 | finance.yahoo.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 27, 2024 | businesswire.comPuma Biotechnology Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)February 22, 2024 | finance.yahoo.comPuma Biotechnology to Participate in a Panel Discussion at TD Cowen’s 44th Annual Health Care ConferenceFebruary 22, 2024 | businesswire.comPuma Biotechnology to Participate in a Panel Discussion at TD Cowen's 44th Annual Health Care ConferenceFebruary 22, 2024 | marketbeat.comFY2025 Earnings Forecast for Puma Biotechnology, Inc. Issued By Zacks Research (NASDAQ:PBYI)Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Zacks Research raised their FY2025 earnings per share estimates for Puma Biotechnology in a report issued on Monday, February 19th. Zacks Research analyst K. Shah now anticipates that the biopharmaceutical company will earn $0.56 per share foFebruary 21, 2024 | msn.comPuma Biotech (PBYI) Is Up 23.01% in One Week: What You Should KnowFebruary 21, 2024 | marketbeat.comPuma Biotechnology, Inc. (NASDAQ:PBYI) to Post FY2024 Earnings of $0.42 Per Share, Zacks Research ForecastsPuma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) - Investment analysts at Zacks Research increased their FY2024 earnings per share (EPS) estimates for Puma Biotechnology in a research note issued on Monday, February 19th. Zacks Research analyst K. Shah now expects that the biopharmaceutical cFebruary 15, 2024 | finance.yahoo.comPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsFebruary 15, 2024 | businesswire.comPuma Biotechnology to Host Conference Call to Discuss Fourth Quarter and Full Year 2023 Financial ResultsFebruary 14, 2024 | marketbeat.comPuma Biotechnology (NASDAQ:PBYI) Stock Rating Lowered by StockNews.comStockNews.com downgraded Puma Biotechnology from a "strong-buy" rating to a "buy" rating in a report on Wednesday.February 13, 2024 | wsj.comPuma Biotechnology Inc.February 13, 2024 | finance.yahoo.comPuma Biotechnology Announces Initiation of ALISCA-Lung1 Phase II Trial of Alisertib in Small Cell Lung CancerFebruary 9, 2024 | msn.comPBYI vs. AMGN: Which Stock Should Value Investors Buy Now?February 9, 2024 | marketbeat.comAssenagon Asset Management S.A. Sells 154,179 Shares of Puma Biotechnology, Inc. (NASDAQ:PBYI)Assenagon Asset Management S.A. reduced its position in Puma Biotechnology, Inc. (NASDAQ:PBYI - Free Report) by 69.0% in the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 69,142 shares of the biopharmaceutical companyFebruary 7, 2024 | finance.yahoo.comImmunome (IMNM) to Acquire Desmoid Tumor Candidate, Stock UpFebruary 6, 2024 | marketbeat.com3 small-cap biotechs with potential breakthroughs in 2024 (PBYI)These small-cap biotech stocks feature large addressable markets combined with positive analyst sentiment and potential breakthroughs in 2024.February 5, 2024 | finance.yahoo.comNovo Nordisk (NVO) to Acquire 3 Catalent Sites for $11B Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Does this make you sick? (Ad)The US Dollar Is "Finished" A deteriorating economy, global instability, and a weakened banking system have pushed the U.S. financial system to the brink, imperiling the value of your savings and investments. Get your Free Wealth Protection Kit PBYI Media Mentions By Week PBYI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. PBYI News Sentiment▼0.000.42▲Average Medical News Sentiment PBYI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. PBYI Articles This Week▼02▲PBYI Articles Average Week Get Puma Biotechnology News Delivered to You Automatically Sign up to receive the latest news and ratings for PBYI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Generation Bio News Today Foghorn Therapeutics News Today G1 Therapeutics News Today 2seventy bio News Today Omeros News Today Pyxis Oncology News Today Aldeyra Therapeutics News Today Ovid Therapeutics News Today Eliem Therapeutics News Today Design Therapeutics News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:PBYI) was last updated on 5/19/2024 by MarketBeat.com Staff From Our PartnersCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingUrgent Nvidia WarningAltimetryShocking $16T Elon Musk Crypto LeakCrypto 101 MediaNext President (Not Trump. Not Biden.)The Freeport SocietyDems have chosen Biden replacement?Paradigm Press41 banks launch ‘crypto dollar’Stansberry ResearchMost important medical advance in 100 yearsThe Oxford Club4 Cryptos BETTER than BitcoinTrue Market Insiders Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Puma Biotechnology, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
